PREMIER Biosoft Announces Reseller Agreement with Bruker
News Nov 17, 2014
PREMIER Biosoft and Bruker Corporation have entered a reselling agreement pursuant to which Bruker will co-market and resell Premier's SimLipid® and SimMet, high throughput informatics tools for lipid and metabolite data analysis.
Integration with Bruker's mass spectrometric workflows will enable new powerful ways for researchers to seamlessly generate, process, and analyze data. Bruker's instruments produce highly accurate broad spectrum data with excellent resolution. SimMet and SimLipid, coupled with Bruker's robust analysis platform, would facilitate automatic LC-MS and MS/MS data processing workflows and accurate identification and quantification of lipids and metabolites.
According to Aiko Barsch, Market Manager at Bruker Corp., "The opportunity to combine Premier's informatics expertise with Bruker's industry leading mass spectrometers will create significant benefits for the metabolomics and lipidomics research community. With this collaboration, we hope to address several of the challenges in advanced biomarker and translational research"
"Our first offering to the mass spectrometry community, SimGlycan, has received excellent acceptance in the market. With SimLipid and SimMet, we hope to serve the research community even further with advancements in data interpretation and visualization," said Arun Apte, CEO at PREMIER Biosoft.
Cancer Cells’ Energy Source Blocked by Natural CompoundNews
Researchers have not only untangled an unusual wiring system that cancer cells use for carbohydrate metabolism, but also identified a natural compound that appears to selectively shut down this system in laboratory studies.READ MORE
SCIEX Receive Science and Technology Award at HUPO 2017News
Two researchers from SCIEX received the HUPO 2017 award at the 16th Human Proteome Organization World Congress in Dublin, Ireland.READ MORE
$2.5M Contract Awarded to ChromaTan to Develop Continuous Purification PlatformNews
ChromaTan Corporation, a provider of continuous and single-use chromatography solutions for the biotechnology industry, has been awarded a $2.5M contract from the Food and Drug Administration (FDA).READ MORE